Vaccinogen produces personalized treatments that use the patient's immune system to fight the disease.
Vaccinogen produces personalized treatments that use the patient's immune system to fight the disease.
Vaccinogen is committed to transforming cancer care by reducing recurrence through personalized treatments. Our innovative therapies empower the immune system to detect and eliminate residual tumor cells, offering patients renewed hope after surgery.
OncoVAX® is an autologous cancer treatment manufactured with a patented process to leverage a patient’s own tumor cells to launch a potent and customized immune response.
Vaccinogen seeks to parter with investors to bring to market the first commercializable, personal cellular therapy for treating an unmet medical need in early stage colon cancer and in combinatorial studies with advanced cancers